BÜHLMANN Laboratories AG acquired by KLAR Partners to support the continued growth of the Company! - BÜHLMANN Laboratories AG (“BÜHLMANN”) announces the closing of the acquisition by funds advised by KLAR Partners Limited (“KLAR Partners” or “KLAR”) today June 5th, 2024. The acquisition enables BÜHLMANN to support its future as a leading independent specialty in-vitro diagnostics company.
EAACI Poster Presentations - Discover the latest advancements from the EAACI 2023 Congress in Hamburg, featuring three insightful posters on the Basophil Activation Test. Topics include validation studies, technical cut-offs, and automated gating strategies.
BÜHLMANN posters at WorldLab 2024 Dubai! - From gastroenterology to neuroimmunology, read the newest developments from BÜHLMANN in our posters presented at the WorldLab 2024!

EULAR 2024

Date: 12– 15 June 2024
Location: Vienna, Austria

EULAR – Annual European Congress of Rheumatology

ÖGGH 2024

Date: 12– 15 June 2024
Location: Salzburg, Austria

57. Jahrestagung & 34. Fortbildungskurs der ÖGGH

Paris IBD Exchange

Date: 28– 29 June 2024
Location: Neuilly sur Seine, France

2nd Paris IBD Exchange